ADC Therapeutics (ADC Therapeutics) Market Cap : $358.18 Mil (As of Apr. 29, 2024)

View and export this data going back to 2020. Start your Free Trial

What is ADC Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ADC Therapeutics's share price for the quarter that ended in Dec. 2023 was $1.66. ADC Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 82.29 Mil. Therefore, ADC Therapeutics's market cap for the quarter that ended in Dec. 2023 was $136.61 Mil.

ADC Therapeutics's quarterly market cap declined from Jun. 2023 ($173.38 Mil) to Sep. 2023 ($73.82 Mil) but then increased from Sep. 2023 ($73.82 Mil) to Dec. 2023 ($136.61 Mil).

ADC Therapeutics's annual market cap declined from Dec. 2021 ($1,551.57 Mil) to Dec. 2022 ($309.67 Mil) and declined from Dec. 2022 ($309.67 Mil) to Dec. 2023 ($136.61 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ADC Therapeutics's Enterprise Value for Today is $203.96 Mil.

ADC Therapeutics Market Cap Historical Data

The historical data trend for ADC Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADC Therapeutics Market Cap Chart

ADC Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

2,455.86

1,551.57

309.67

136.61

ADC Therapeutics Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															309.67	157.25	173.38	73.82	136.61

Competitive Comparison of ADC Therapeutics's Market Cap

For the Biotechnology subindustry, ADC Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ADC Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADC Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where ADC Therapeutics's Market Cap falls into.

ADC Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

ADC Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$1.66	*	82.2931
	=	$136.61

ADC Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	$1.66	*	82.2931
	=	$136.61

ADC Therapeutics (NYSE:ADCT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

ADC Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of ADC Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

ADC Therapeutics (ADC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

Route de la Corniche 3B, Biopole, Epalinges, CHE, 1066

Website

https://www.adctherapeutics.com

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.